These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24051551)

  • 1. Diastolic dysfunction and high levels of new cardiac biomarkers as risk factors for cardiovascular events and mortality in hemodialysis patients.
    Quiroga B; Villaverde M; Abad S; Vega A; Reque J; López-Gómez JM
    Blood Purif; 2013; 36(2):98-106. PubMed ID: 24051551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA
    Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor as a new predictor of mortality among chronic kidney disease patients treated with hemodialysis.
    Terawaki H; Yamagishi S; Funakoshi Y; Matsuyama Y; Terada T; Nakayama K; Ogura M; Hosoya T; Ito S; Era S; Nakayama M
    Ther Apher Dial; 2013 Dec; 17(6):625-30. PubMed ID: 24330558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cardiovascular event rates occur within the first weeks of starting hemodialysis.
    Eckardt KU; Gillespie IA; Kronenberg F; Richards S; Stenvinkel P; Anker SD; Wheeler DC; de Francisco AL; Marcelli D; Froissart M; Floege J;
    Kidney Int; 2015 Nov; 88(5):1117-25. PubMed ID: 25923984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular mass index and aortic arch calcification score are independent mortality predictors of maintenance hemodialysis patients.
    Liu S; Zhang DL; Guo W; Cui WY; Liu WH
    Hemodial Int; 2012 Oct; 16(4):504-11. PubMed ID: 22520823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma DHEA-S increases mortality risk among male hemodialysis patients.
    Hsu HJ; Yen CH; Chen CK; Hsu KH; Hsiao CC; Lee CC; Wu IW; Sun CY; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
    Exp Gerontol; 2012 Dec; 47(12):950-7. PubMed ID: 22974561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased IGF-1 levels potentiate association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients.
    Beberashvili I; Sinuani I; Azar A; Kadoshi H; Shapiro G; Feldman L; Sandbank J; Averbukh Z
    Growth Horm IGF Res; 2013 Dec; 23(6):209-14. PubMed ID: 23958273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients.
    Wu CC; Liou HH; Su PF; Chang MY; Wang HH; Chen MJ; Hung SY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3689-95. PubMed ID: 21357211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
    Winther S; Christensen JH; Flyvbjerg A; Schmidt EB; Jørgensen KA; Skou-Jørgensen H; Svensson M
    Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R; Allison MA; Criqui MH
    J Am Coll Cardiol; 2007 Jun; 49(22):2172-81. PubMed ID: 17543637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.
    Kuwahara M; Takehara E; Sasaki Y; Azetsu H; Kusaka K; Shikuma S; Akita W
    Ther Apher Dial; 2016 Feb; 20(1):12-9. PubMed ID: 26679409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk markers in hemodialysis].
    Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of BNP and NT-proBNP in hemodialysis patients.
    Sun L; Sun Y; Zhao X; Xu C; Chen D; Li L; Ma Y; Rong S; Mei C
    Nephron Clin Pract; 2008; 110(3):c178-84. PubMed ID: 18957868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality.
    Beaubien ER; Pylypchuk GB; Akhtar J; Biem HJ
    Am J Kidney Dis; 2002 Apr; 39(4):834-42. PubMed ID: 11920351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients.
    Shoji T; Marubayashi S; Shigematsu T; Iseki K; Tsubakihara Y; ;
    Ther Apher Dial; 2015 Jun; 19(3):235-44. PubMed ID: 25530222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.